Pfizer CEO: “Likely” need for third dose months later

Katie Lannan

Pfizer’s chief executive believes it’s “likely” that people will need a third dose of COVID-19 vaccine somewhere between six and twelve months after their second shot, and that annual coronavirus vaccines are a possibility.

CNBC reported CEO Albert Bourla’s comments Thursday, saying the remarks had now been made public after they were recorded on April 1 during an event with CVS Health.

“A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months and then from there, there will be an annual revaccination, but all of that needs to be confirmed. And again, the variants will play a key role,” Bourla said to CNBC’s Bertha Coombs.